Foamix receives milestone from Bayer

• Foamix Pharmaceuticals (FOMX -1.5%) receives a $2.5M milestone payment from Bayer Healthcare (OTCPK:BAYRY +1.1%) under its license agreement for a foam vehicle for azelaic acid. Additional terms of the contract are undisclosed.